A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept
After Bone Marrow Transplantation, the Cell-Intrinsic Th2 Pathway Promotes Recipient T Lymphocyte Survival and Regulates Graft-versus-Host Disease
Development of a Liquid Chromatography and High-Resolution and -Accuracy Mass Spectrometry Method to Evaluate New Biotherapeutic Entity Processing in Human Liver Lysosomes
CLINICAL AND TRANSLATIONAL IMMUNOLOGY
On the cover: A heatmap showing correlation (more red) and anticorrelation (more blue) of nasal mucosal cytokines, chemokines, and growth factors in hematopoietic cell transplant recipients suspected to have lung graft-versus-host disease. Clear clusters of type 1, type 2, and type 17 inflammation are evident; early lung graft-versus-host disease is characterized by nasal type 2 and type 17 inflammation. Ostrin, E. J., N. L. Rider, A. M. Alousi, E. Irajizad, L. Li, Q. Peng, S. T. Kim, L. Bashoura, M. H. Arain, L. Z. Noor, N. Patel, R. Mehta, U. R. Popat, C. Hosing, R. R. Jenq, G. Rondon, S. M. Hanash, S. Paczesny, E. J. Shpall, R. E. Champlin, B. F. Dickey, and A. Sheshadri. 2023. A nasal inflammatory cytokine signature is associated with early graft-versus-host disease of the lung after allogeneic hematopoietic cell transplantation: proof of concept. ImmunoHorizons 7: 421–430.
- PDF Icon PDF LinkEditorial Board